How has been the historical performance of Aarti Pharma?

Answer:The historical performance of Aarti Pharma shows significant growth over the years, particularly from March 2021 to March 2025.

Breakdown:
Aarti Pharma's net sales have increased from zero in March 2021 to 2,115.07 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from zero to 2,115.07 crore in the same period. The company's total expenditure, excluding depreciation, also grew, reaching 1,650.71 crore in March 2025, up from zero in March 2021. Operating profit (PBDIT) has shown consistent growth, climbing from zero to 474.48 crore, with an operating profit margin of 21.95% in March 2025. Profit before tax increased from zero to 360.69 crore, while profit after tax rose to 272.40 crore from zero in March 2021. The earnings per share (EPS) improved significantly, reaching 30.05 in March 2025. On the balance sheet, total assets grew from 0.25 crore in March 2021 to 2,906.41 crore in March 2025, with total liabilities also increasing to 2,906.41 crore. The cash flow from operating activities showed a positive trend, reaching 331 crore in March 2025, although the net cash outflow was -16 crore. Overall, Aarti Pharma's financial performance indicates robust growth and improving profitability over the years.